ResearcherEdinburgh Cancer ResearchActive in the last 2 years

Marta Canel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3390-0705; OpenAlex author ID A5089581432. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

Tumour genotype shapes blood biomarker expression for use in pancreatic cancer detection and diagnosis Co-author DOI 10.1101/2025.08.15.670486 ↗
FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2022-327927 ↗
FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer. Co-author DOI 10.1038/s41416-022-01966-5 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Alan Serrels · 3 shared papers, 2022–2025 · strength 0.64
Catherine Davidson · 2 shared papers, 2022–2023 · strength 0.36
- Paper FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer. DOI 10.1038/s41416-022-01966-5 ↗
- Paper FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer. DOI 10.1136/gutjnl-2022-327927 ↗
Jennifer P. Morton · 1 shared paper, 2025 · strength 0.28
- Paper Tumour genotype shapes blood biomarker expression for use in pancreatic cancer detection and diagnosis DOI 10.1101/2025.08.15.670486 ↗
Andrew Victor Biankin · 1 shared paper, 2023 · strength 0.17
- Paper FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer. DOI 10.1136/gutjnl-2022-327927 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.